AbbVie (ABBV) announced updated results from the Phase 1b/2 EPCORE NHL-2 trial evaluating fixed-duration investigational epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered ...
The foreign ministry of Russia, a longtime ally, did not provide details on where President Bashar al-Assad had gone. Rebels stormed the Syrian capital on Sunday without encountering any ...